Author:
Fallahi Babak,Esmaeili Atefe,Beiki Davood,Oveisgharan Shahram,Noorollahi-Moghaddam Hamid,Erfani Mostafa,Tafakhori Abbas,Rohani Mohammad,Fard-Esfahani Armaghan,Emami-Ardekani Alireza,Geramifar Parham,Eftekhari Mohammad
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging,General Medicine
Reference23 articles.
1. Swanson RL, Newberg AB, Acton PD, Siderowf A, Wintering N, Alavi A, et al. Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson’s disease. Eur J Nucl Med Mol Imaging. 2005;32:302–7.
2. Zhang L, Liu J. The role of neuroimaging in the diagnosis of Parkinson’s disease. Int J Integr Med. 2013;1:1–5.
3. Chaudhuri KR, Ondo WG. Movement disorders in clinical practice. London: Springer-Verlag; 2010.
4. Shih MC, Hoexter MQ, Andrade LA, Bressan RA. Parkinson’s disease and dopamine transporter neuroimaging: a critical review. Sao Paulo Med J. 2006;124:168–75.
5. Wang L, Zhang Q, Li H, Zhang H. SPECT molecular imaging in Parkinson’s disease. J Biomed Biotechnol. 2012;2012:412486.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献